PubRank

C Auriault

Author PubWeight™ 93.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A new function for platelets: IgE-dependent killing of schistosomes. Nature 1983 2.11
2 The receptor for IgE on blood platelets. Eur J Immunol 1986 1.32
3 Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998 1.29
4 Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol 1988 1.15
5 Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni. Infect Immun 1999 1.08
6 Protective role of IgE in immunocompromised rat toxoplasmosis. J Immunol 1988 1.07
7 Infection of B-cell-deficient mice by the parasite Schistosoma mansoni: demonstration of the participation of B cells in granuloma modulation. Scand J Immunol 1998 1.05
8 In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania. Eur J Immunol 1989 1.04
9 Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells. Infect Immun 1990 1.03
10 Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells. Eur J Immunol 1991 1.03
11 New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol 1985 1.03
12 Recombinant tumor necrosis factors mediate platelet cytotoxicity to Schistosoma mansoni larvae. J Immunol 1988 1.02
13 Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection. Eur Cytokine Netw 1997 1.01
14 Platelet cytotoxicity against parasites. Nouv Rev Fr Hematol 1991 0.98
15 Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J Immunol 1992 0.98
16 Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. J Infect Dis 2000 0.97
17 IgE-dependent killing of Brugia malayi microfilariae by human platelets and its modulation by T cell products. Int Arch Allergy Appl Immunol 1988 0.97
18 Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization. J Immunol 1991 0.96
19 Protective effect of rSm28GST-specific T cells in schistosomiasis: role of gamma interferon. Infect Immun 1994 0.95
20 Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Mol Immunol 1994 0.95
21 Rat IgE directed against schistosomula-released products is cytotoxic for Schistosoma mansoni schistosomula in vitro. Eur J Immunol 1984 0.95
22 Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma. J Immunol 1987 0.94
23 Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide. Scand J Immunol 1996 0.93
24 Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood 1997 0.92
25 Identification of T cell epitopes within a 23-kD antigen (P24) of Toxoplasma gondii. Clin Exp Immunol 1991 0.91
26 IFN-gamma-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells. J Med Chem 1999 0.91
27 Characterization and synthesis of a macrophage inhibitory peptide from the second constant domain of human immunoglobulin G. FEBS Lett 1983 0.91
28 Inhibitory effects of cyclosporine on human regulatory T cells in vitro. Transplant Proc 2009 0.91
29 Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen. J Immunol 1989 0.90
30 Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells. Trop Med Int Health 1999 0.89
31 A suppressive lymphokine of platelet cytotoxic functions. J Immunol 1986 0.89
32 Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res 1994 0.89
33 Neutral protease activities at different developmental stages of Schistosoma mansoni in mammalian hosts. Comp Biochem Physiol B 1982 0.89
34 Proteolytic cleavage of IgG bound to the Fc receptor of Schistosoma mansoni schistosomula. Parasite Immunol 1981 0.89
35 Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies. Clin Exp Immunol 1986 0.88
36 Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis. Gene Ther 2003 0.88
37 Schistosomal egg antigen-responsive CD8 T-cell population in Schistosoma mansoni-infected BALB/c mice. Immunology 1999 0.87
38 Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene. Clin Exp Immunol 2002 0.87
39 [Infection of the athymic rat by Toxoplasma gondii]. C R Acad Sci III 1987 0.87
40 Does Epstein-Barr virus infection confer selective advantage to malaria-infected children? Lancet 1993 0.87
41 Platelets as effectors in immune and hypersensitivity reactions. Int Arch Allergy Appl Immunol 1987 0.87
42 Unrestricted agonist activity on murine and human cells of a lipopeptide derived from IFN-gamma. Biochem Biophys Res Commun 1998 0.87
43 Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant 2009 0.87
44 Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha. Blood 1992 0.86
45 Effect of ubiquitin on platelet functions: possible identity with platelet activity suppressive lymphokine (PASL). Eur J Immunol 1991 0.85
46 Analysis of the V beta specificity of superantigen activation with a rapid and sensitive method using RT PCR and an automatic DNA analyser. J Immunol Methods 1994 0.85
47 Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration. Clin Exp Immunol 1986 0.85
48 Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni. J Immunol 1987 0.84
49 Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infection. J Immunol 1998 0.84
50 A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases. J Immunol Methods 1994 0.84
51 Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease. Immunology 1997 0.83
52 Fast evolution of interleukin-2 in mammals and positive selection in ruminants. J Mol Evol 2000 0.83
53 Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunol 1997 0.82
54 Induction of a protective immune IgE response in rats by injection of defined antigens of schistosomulum-released products: immunochemical properties of the target antigens. Int Arch Allergy Appl Immunol 1986 0.82
55 Measurement of picogram quantities of rat IgE from in vitro culture supernatants of B lymphocytes in experimental helminth infections. Int Arch Allergy Appl Immunol 1986 0.82
56 Detection of human antibodies using "convergent" combinatorial peptide libraries or "mixotopes" designed from a nonvariable antigen: application to the EBV viral capsid antigen p18. J Pept Res 1998 0.82
57 Schistosoma mansoni-infected mice show augmented hepatic fibrosis and selective inhibition of liver cytokine production after treatment with anti-NK1.1 antibodies. Immunol Lett 1996 0.81
58 IgG subclass-associated differences in anti-schistosomal antibody specificity. Scand J Immunol 1994 0.81
59 Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection. J Clin Microbiol 1999 0.81
60 Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cells. Vaccine 1994 0.81
61 IgE-dependent killing of Schistosoma mansoni schistosomula by human platelets: modulation by T cell products. Int Arch Allergy Appl Immunol 1988 0.81
62 Adaptation of BTI-TN5B1-4 (high five) insect cells for large-scale production in a stirred bioreactor. Biotechniques 1999 0.81
63 Cutaneous interleukin-7 transgenic mice display a propitious environment to Schistosoma mansoni infection. Parasite Immunol 2001 0.81
64 Structural diversity of human class II histocompatibility molecules induced by peptide ligands. FEBS Lett 2000 0.81
65 [Hodgkin's disease and Epstein-Barr virus]. Ann Biol Clin (Paris) 2004 0.80
66 Immunological response of major histocompatibility complex class II-deficient (Abeta(o)) mice infected by the parasite Schistosoma mansoni. Scand J Immunol 1998 0.80
67 Activation of rat and human eosinophils by soluble factor(s) released by Schistosoma mansoni Schistosomula. Cell Immunol 1982 0.80
68 Regulatory role of a tripeptide (TKP) from the second constant domain of immunoglobulin G--I. Inhibition of rat and human macrophage activities. Int J Immunopharmacol 1985 0.80
69 IgG response of rats and humans to the released products of schistosomula of Schistosoma mansoni. Parasitology 1985 0.80
70 Properties of serine proteases of Schistosoma mansoni schistosomula involved in the regulation of IgE synthesis. Scand J Immunol 1988 0.80
71 IgE-dependent platelet cytotoxicity against helminths. Adv Exp Med Biol 1985 0.80
72 Direct evidence of cytoplasmic delivery of PKC-alpha, -epsilon and -zeta pseudosubstrate lipopeptides: study of their implication in the induction of apoptosis. FEBS Lett 1999 0.80
73 Convergent peptide libraries, or mixotopes, to elicit or to identify specific immune responses. Curr Opin Immunol 1999 0.80
74 T-cell responsiveness towards various synthetic peptides of the P28 antigen in rat and mouse models during Schistosoma mansoni infection. Int Arch Allergy Appl Immunol 1990 0.80
75 The mixotope: a combinatorial peptide library as a T cell and B cell immunogen. Eur J Immunol 1994 0.79
76 Interleukin-6 is the main mediator of the interaction between monocytes and platelets in the killing of Schistosoma mansoni. Eur Cytokine Netw 1991 0.79
77 Determination of B-cell epitopes of nef HIV-I protein: immunogenicity related to their structure. Mol Immunol 1992 0.79
78 HLA class II polymorphism influences onset and severity of pathology in Schistosoma mansoni-infected transgenic mice. Infect Immun 2001 0.79
79 [Antigens of Toxoplasma gondii with a diagnostic and potential immunoprophylactic value: new strategies of identification]. Ann Biol Clin (Paris) 1989 0.79
80 Defined antigens secreted by the larvae of schistosomes protect against schistosomiasis: induction of cytotoxic antibodies in the rat and the monkey. Eur J Immunol 1985 0.79
81 Macrophages as effector cells in helminth infections. Trans R Soc Trop Med Hyg 1983 0.79
82 Evaluation of the effect of Sm28GST-derived peptides in murine hepatosplenic schistosomiasis: interest of the lipopeptidic form of the C-terminal peptide. Mol Immunol 1994 0.78
83 Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis. J Immunol 1991 0.78
84 Role of interleukin-7 in the relation between Schistosoma mansoni and its definitive vertebrate host. Microbes Infect 1999 0.78
85 Novel hyperbranched glycomimetics recognized by the human mannose receptor: quinic or shikimic acid derivatives as mannose bioisosteres. Chembiochem 2001 0.78
86 Homologous T and B cells immortalized in vitro by the Epstein-Barr virus exhibit differential genetical and functional features. Int J Oncol 1997 0.78
87 Role of serine proteases of Schistosoma mansoni in the regulation of IgE synthesis. Scand J Immunol 1986 0.78
88 Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells. Clin Exp Immunol 2002 0.78
89 Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum 1999 0.78
90 Biological effect of interferon-gamma during the course of experimental infection of rat by Schistosoma mansoni. Cell Immunol 1990 0.77
91 Antigenic properties of Schistosoma mansoni aminopeptidases: evolution during the development in mammalian hosts. Mol Biochem Parasitol 1982 0.77
92 Differential effect of cyclosporin A (CyA) on IgE response: role of CyA-induced suppressor cells. Immunol Lett 1987 0.77
93 Interaction between macrophages and Schistosoma mansoni schistosomula: role of IgG peptides and aggregates on the modulation of beta-glucuronidase release and the cytotoxicity against schistosomula. Cell Immunol 1981 0.77
94 Analysis of antigenicity and immunogenicity of five different chemically defined constructs of a peptide. Mol Immunol 1992 0.77
95 Characterization of a suppressive factor of platelet cytotoxic functions in human and rat schistosomiasis mansoni. Clin Exp Immunol 1989 0.77
96 Comprehensive delineation of antigenic and immunogenic properties of peptides derived from the nef HIV-1 regulatory protein. Vaccine 1993 0.76
97 Helper T cells induced by a purified 28-kilodalton antigen of Schistosoma mansoni protect rats against infection. Infect Immun 1987 0.76
98 GP38, P28-I and P28-II: candidates for a vaccine against schistosomiasis. Mem Inst Oswaldo Cruz 1987 0.76
99 Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii. Eur Cytokine Netw 1992 0.76
100 T-cell-dependent immunity and thrombocytopenia in rats infected with Plasmodium chabaudi. Infect Immun 1992 0.76
101 Protection of rats against Schistosoma mansoni infection induced by platelets stimulated with the murine recombinant tumor necrosis factor alpha. Int Arch Allergy Appl Immunol 1990 0.76
102 T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees. Mol Immunol 1992 0.76
103 Comparison of the immune response elicited by a free peptide and a lipopeptide construct. Pept Res 1997 0.76
104 Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters. Eur Cytokine Netw 1999 0.76
105 Human recombinant gamma-interferon stimulates proliferation and inhibits collagen and fibronectin production by human dental pulp fibroblasts. Cell Mol Biol 1989 0.76
106 Regulation of IgE synthesis by macrophages expressing FcE-receptors: role of interleukin 1. Clin Exp Immunol 1987 0.75
107 The neuropeptide substance P stimulates the effector functions of platelets. Clin Exp Immunol 1990 0.75
108 Generation and functional analysis of T cell lines and clones specific for schistosomula released products (SRP-A). Clin Exp Immunol 1987 0.75
109 Regulatory role of a peptide from the second constant domain of immunoglobulin G--II. In vitro effect on granuloma formation around S. mansoni eggs. Int J Immunopharmacol 1985 0.75
110 Improvement of the T-cell response to a non immunogenic peptide by its tandem association with a highly efficient T-helper peptide. Immunopharmacology 1995 0.75
111 [Regulatory T-cells and hepatocellular carcinoma: implication of the regulatory T lymphocytes in the control of the immune response]. Bull Cancer 2008 0.75
112 Murine interleukin-4 production with baculovirus: an easy and rapid method for a small scale production of functional interleukins. Eur Cytokine Netw 1995 0.75
113 Improvement of the T-cell response to a non-immunogenic peptide by its tandem association with a highly efficient T-helper peptide. Immunopharmacology 1995 0.75
114 Combinatorial peptide library as an immunogen. Methods Mol Biol 1998 0.75
115 Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula. J Immunol 1981 0.75
116 IFN-gamma treatment of rodents infected with erythrocytic stages of Plasmodium chabaudi: differential effects according to the immunological status. Int J Immunopharmacol 1993 0.75
117 [Analysis of peptides associated with class II MHC molecules, HLA-DR3: implication for the prediction of peptides useful for vaccines]. C R Acad Sci III 1996 0.75
118 Enhancement of eosinophil effector function by soluble factors released by S. mansoni: role of proteases. J Immunol 1983 0.75
119 Aminopeptidase activity in adult Schistosoma mansoni. J Parasitol 1983 0.75
120 Recombinant human interferon-gamma induces increased IgE receptor expression on human platelets. Eur J Immunol 1988 0.75
121 Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. I. Role in the anti-S. mansoni antibody response. J Immunol 1991 0.75
122 Non-specific potentiation of T- and B-lymphocyte proliferation at the early stage of infection by Schistosoma mansoni: role of factors secreted by the larvae. Parasite Immunol 1984 0.75
123 A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses. J Pept Sci 1997 0.75
124 Identification and characterization of a functional receptor for interferon-gamma on a megakaryocytic cell line. Blood 1991 0.75